NPI registry status
Active
2026 NPPES data Colon & Rectal Surgery Physician NPI 1225245947 M.D.
Verify on CMS → Julie Lorber, M.D.
Colon & Rectal Surgery Physician in Summit, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,608 in Colon & Rectal Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
263
Medicare Part D claims · 109 beneficiaries · Colon & Rectal Surgery Physician avg: 196
Generic prescribing
68%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
46.4/100
▼ 37 pts below national avg 83.1 · Below average
Industry payments
$235.06
12 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Julie Lorber, M.D. reported a CMS MIPS final score of 46.4/100 - below the 83.1 national average - and filed 263 Medicare Part D claims in 2023.
- 46.4/100
- MIPS score · -37 vs avg
- 263
- Part D claims, 2023
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Julie Lorber, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
46 4th percentile higher than 4% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Julie Lorber, M.D. sits
This provider among colon & rectal surgery physician peers
Across the 536 colon & rectal surgery physician providers who report both Medicare Part D prescribing and a MIPS quality score, Julie Lorber, M.D. writes more Part D claims than 72% of them and scores higher on MIPS quality than 6% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one colon & rectal surgery physician peer from a representative sample of 60; the gold marker is Julie Lorber, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Julie Lorber, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Julie Lorber, M.D.?
Below national averagePrimary specialty
Colon & Rectal Surgery Physician
Medicare Part D claims
263 34% vs specialty avg
MIPS final score
46.4/100 36.7 pts vs avg
Specialty distribution in New Jersey
How Colon & Rectal Surgery Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Julie Lorber, M.D.'s 2023 MIPS final score plotted against the Colon & Rectal Surgery Physician national average
- MIPS Final Score
- 46.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Colon & Rectal Surgery Physician) - 46.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Julie Lorber, M.D. appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding M.D. credentials at 33 OVERLOOK RD, Summit, NJ, 07901, with a listed phone of (908) 273-2886. NPI 1225245947 was issued on 05/16/2007.
Medicare Part D records for calendar year 2023 show 263 prescription claims written by this provider, covering 109 Medicare beneficiaries and totaling roughly $80K in drug spend, split 27% brand-name and 68% generic by claim count, with an opioid prescribing rate of 6.5%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 46.4/100 for the 2023 performance year (Quality 56.2, Cost 79.6), compared with the national average of 83.1.
Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225245947 |
|---|---|
| Specialty | Colon & Rectal Surgery Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/16/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
46.354
Final Score
Avg: 83.1
56.1912
Quality
79.5919
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Julie Lorber, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$235
Largest payer
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Julie Lorber, M.D. - brand share 27.0%
Colon & Rectal Surgery Physician average
27% brand-name claims vs 68% generic, on 263 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
263
Total Claims
$80K
Total Drug Cost
109
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 340
- Total Day Supply
- 7,456
- Brand vs Generic
- 27% brand / 68% generic
- Brand Drug Cost
- $36K
- Generic Drug Cost
- $24K
- Opioid Claims
- 17 (6.5% rate)
- Antibiotic Claims
- 32
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.13
- Gender Split
- 78% female / 22% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Julie Lorber, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Mesalamine Er
Mesalamine Er
31 claims
- Metronidazole
Metronidazole
17 claims
- Clobetasol Propion…
Clobetasol Propionate
14 claims
- Opium Tincture
Opium Tincture
13 claims
- Sutab
Sutab
13 claims
- Budesonide Dr 11
Budesonide Dr
11 claims
- Motegrity 11
Motegrity
11 claims
- Oxycodone Hcl 11
Oxycodone Hcl
11 claims
| Drug | Claims |
|---|---|
| Mesalamine Er Mesalamine | 31 |
| Metronidazole | 17 |
| Clobetasol Propionate | 14 |
| Opium Tincture | 13 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 13 |
| Budesonide Dr Budesonide | 11 |
| Motegrity Prucalopride Succinate | 11 |
| Oxycodone Hcl | 11 |
| Sod Sulf-Potass Sulf-Mag Sulf "Sodium | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Colon & Rectal Surgery Physician Overview
How Julie Lorber, M.D. fits within the Colon & Rectal Surgery Physician landscape nationally.
1,608
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
196
Avg Claims per Provider
Julie Lorber, M.D.'s 263 claims are above the specialty average of 196.
Nearby Colon & Rectal Surgery Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Lorber.
Analena Alcabes
South Plainfield, NJ
Dr. Marjan Aleali
MD
Maywood, NJ
Dr. Melissa Alvarez-Downing
M.D.
Newark, NJ
Dr. Michael Arvanitis
MD
Eatontown, NJ
Dr. Gregg Baranski
M.D.
Moorestown, NJ
Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Colon & Rectal Surgery Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New Jersey
Frequently Asked Questions
What is Julie Lorber, M.D.'s specialty? ▼
Julie Lorber, M.D. specializes in Colon & Rectal Surgery Physician and practices in Summit, New Jersey. Credentials: M.D..
How much does Julie Lorber, M.D. prescribe under Medicare Part D? ▼
In 2023, Julie Lorber, M.D. wrote 263 Medicare Part D claims totaling $80K in drug costs for 109 beneficiaries.
What is Julie Lorber, M.D.'s Medicare quality score? ▼
Julie Lorber, M.D. has a CMS MIPS Final Score of 46.4/100 (Quality: 56.2, Cost: 79.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Julie Lorber, M.D. located? ▼
Julie Lorber, M.D. is located at 33 OVERLOOK RD, Summit, NJ, 07901. Phone: (908) 273-2886.
What is Julie Lorber, M.D.'s NPI number? ▼
Julie Lorber, M.D.'s National Provider Identifier (NPI) is 1225245947, issued on 05/16/2007.
Does Julie Lorber, M.D. prescribe more brand-name or generic drugs? ▼
Julie Lorber, M.D.'s prescribing is 27% brand-name and 68% generic drugs by claim count, with $36K in brand drug costs.
Does Julie Lorber, M.D. prescribe opioids? ▼
Yes, Julie Lorber, M.D. had 17 opioid claims in 2023 with an opioid prescribing rate of 6.5%.
How many Colon & Rectal Surgery Physician providers are there in the US? ▼
There are 1,608 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 196 Medicare Part D claims per year.
What drugs does Julie Lorber, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Julie Lorber, M.D.'s most frequently prescribed drugs include Mesalamine Er, Metronidazole, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Julie Lorber, M.D. accept Medicare? ▼
Julie Lorber, M.D. appears in CMS Medicare data with 263 Part D claims and 109 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Julie Lorber, M.D.'s credentials? ▼
Julie Lorber, M.D.'s NPI is 1225245947 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.